Bayer Stops Bleeding Drug

Nov 06, 09:30 PM

Current Headlines: By The Associated Press

WASHINGTON Bayer AG halted worldwide sales Monday of its anti- bleeding drug Trasylol at the request of U.S. and foreign health officials pending further analysis of a Canadian study that suggests its linked to a 50 percent higher risk of death than the other drugs in the clinical trial. The Food and Drug Administration asked the company to stop selling the drug, used to prevent excessive bleeding during heart bypass surgery, until it could receive and review further results from the study. The study comparing the safety and efficacy of the drug with two others was recently halted. FDA cannot identify a specific patient population where we believe the benefits of using Trasylol outweighs the risk, said Dr. John Jenkins, director of the agencys Office of New Drugs, during a briefing Monday.

(c) 2007 Charleston Gazette, The. Provided by ProQuest Information and Learning. All rights Reserved.